Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg C Hutterer

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 19, 2009
Survival after radical prostatectomy and radiotherapy for prostate cancer: a population-based studyClaudio Jeldres, Nazareno Suardi, Paul Perrotte, et al.
Urologia Internationalis|March 11, 2010
A nomogram predicting prostate cancer-specific mortality after radical prostatectomyChristopher R Porter, Nazareno Suardi, Umberto Capitanio, et al.
BJU International|September 24, 2013
Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinomaOrietta Dalpiaz, Georg C Ehrlich, Sebastian Mannweiler, et al.
Cancer|October 18, 2007
Cytoreductive nephron-sparing surgery does not appear to undermine disease-specific survival in patients with metastatic renal cell carcinomaGeorg C Hutterer, Jean-Jacques Patard, Marc Colombel, et al.
European Urology|November 13, 2007
Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 menClaudio Jeldres, Nazareno Suardi, Jochen Walz, et al.
Urologic Oncology|May 8, 2019
BioScore (B7-H1, survivin, and Ki-67) does not predict cancer-specific mortality in surgically treated patients with renal cell carcinoma: An external validation studyGeorg C Hutterer, Florian Posch, Lorenz Buser, et al.
BJU International|June 19, 2007
Differences in the rate of lymph node invasion in men with clinically localized prostate cancer might be related to the continent of originAlberto Briganti, Shahrokh F Shariat, Felix K-H Chun, et al.
European Urology|December 18, 2007
Validation of the contemporary epstein criteria for insignificant prostate cancer in European menClaudio Jeldres, Nazareno Suardi, Jochen Walz, et al.
European Urology|November 13, 2007
High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancerClaudio Jeldres, Nazareno Suardi, Fred Saad, et al.
Central European Journal of Urology|April 24, 2019
Prognostic value of B7-H1, B7-H3 and the stage, size, grade and necrosis (SSIGN) score in metastatic clear cell renal cell carcinomaJohannes Mischinger, Eleonore Fröhlich, Sebastian Mannweiler, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 19, 2009
Survival after radical prostatectomy and radiotherapy for prostate cancer: a population-based studyClaudio Jeldres, Nazareno Suardi, Paul Perrotte, et al.
Urologia Internationalis|March 11, 2010
A nomogram predicting prostate cancer-specific mortality after radical prostatectomyChristopher R Porter, Nazareno Suardi, Umberto Capitanio, et al.
BJU International|September 24, 2013
Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinomaOrietta Dalpiaz, Georg C Ehrlich, Sebastian Mannweiler, et al.
Cancer|October 18, 2007
Cytoreductive nephron-sparing surgery does not appear to undermine disease-specific survival in patients with metastatic renal cell carcinomaGeorg C Hutterer, Jean-Jacques Patard, Marc Colombel, et al.
European Urology|November 13, 2007
Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 menClaudio Jeldres, Nazareno Suardi, Jochen Walz, et al.
Urologic Oncology|May 8, 2019
BioScore (B7-H1, survivin, and Ki-67) does not predict cancer-specific mortality in surgically treated patients with renal cell carcinoma: An external validation studyGeorg C Hutterer, Florian Posch, Lorenz Buser, et al.
BJU International|June 19, 2007
Differences in the rate of lymph node invasion in men with clinically localized prostate cancer might be related to the continent of originAlberto Briganti, Shahrokh F Shariat, Felix K-H Chun, et al.
European Urology|December 18, 2007
Validation of the contemporary epstein criteria for insignificant prostate cancer in European menClaudio Jeldres, Nazareno Suardi, Jochen Walz, et al.
European Urology|November 13, 2007
High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancerClaudio Jeldres, Nazareno Suardi, Fred Saad, et al.
Central European Journal of Urology|April 24, 2019
Prognostic value of B7-H1, B7-H3 and the stage, size, grade and necrosis (SSIGN) score in metastatic clear cell renal cell carcinomaJohannes Mischinger, Eleonore Fröhlich, Sebastian Mannweiler, et al.
Pageof 8